Life Science Investing Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
Life Science Investing Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
Life Science Investing Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Homerun Resources Inc. Announces Multi-Process Testing Results for Santa Maria Eterna High-Purity Silica Sand Project
